Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Otezla
Otezla
Yes, Amgen overpaid for Otezla—but that doesn't make it a mistake: analysts
Fierce Pharma
Wed, 08/28/19 - 12:47 pm
Amgen
Otezla
Enbrel
drug reps
M&A
Celgene
Amgen puts out welcome mat for Celgene’s Otezla reps, but will they join—and then stay?
Fierce Pharma
Wed, 08/28/19 - 10:58 am
Amgen
Otezla
drug reps
M&A
Six burning Otezla questions
EP Vantage
Tue, 08/27/19 - 10:53 pm
Celgene
Otezla
Amgen
drug pricing
FTC
Tyk2
Bristol-Myers Squibb
Celgene sells psoriasis pill to Amgen for $13.4 billion, clearing way for close of Bristol merger
Stat
Mon, 08/26/19 - 10:24 am
Amgen
Otezla
Celgene
M&A
Bristol-Myers Squibb
psoriasis
How Big Is Celgene's Latest Good News?
Motley Fool
Sun, 08/18/19 - 12:38 pm
Celgene
Otezla
Revlimid
Inrebic
These 5 Firms Could Buy Celgene's Otezla Ahead Of The Bristol Merger
Investors Business Daily
Fri, 07/19/19 - 10:44 am
Bristol-Myers Squibb
Celgene
M&A
Otezla
Gilead Sciences
Amgen
Regeneron
Eli Lilly
JNJ
FDA Action Alert: Karyopharm, Merck and Celgene
BioSpace
Mon, 07/1/19 - 10:54 pm
FDA
Karyopharm
Selinexor
Merck
relebactam
Celgene
Otezla
The 2 Biggest Casualties From the Celgene-Bristol-Myers Merger (So Far)
Yahoo/Motley Fool
Fri, 06/28/19 - 10:14 am
Bristol-Myers Squibb
Celgene
M&A
BeiGene
tislelizumab
Otezla
Bristol-Myers Squibb: Losing Otezla Might Be Challenging
Market Realist
Tue, 06/25/19 - 09:28 am
Bristol-Myers Squibb
Celgene
M&A
Otezla
In surprise switch, Bristol-Myers is selling off blockbuster Otezla, promising to complete Celgene acquisition — just later
Endpoints
Mon, 06/24/19 - 11:23 am
Bristol-Myers Squibb
Opdivo
Otezla
M&A
FTC
Celgene
Celgene notches positive Otezla data in scalp psoriasis as it guns for market expansion
Fierce Pharma
Tue, 10/9/18 - 11:23 pm
Celgene
Otezla
scalp psoriasis
FDA
5 Things Celgene's Management Just Said That You'll Want to Know
Motley Fool
Sat, 01/27/18 - 09:39 am
Celgene
M&A
Juno Therapeutics
Impact Biomedicines
Otezla
drug pricing
Here's Where Things Went Wrong for Celgene Corporation in 2017
Motley Fool
Fri, 12/29/17 - 10:44 am
Celgene
Otezla
autoimmune disease
R&D
Revlimid
A Me-Too Push By Biopharma Is Crowding the Psoriasis Market
Motley Fool
Sun, 10/29/17 - 09:59 am
psoriasis
me-too drugs
Otezla
Celgene
As Otezla struggles, Celgene wipes $1 to $2 billion off its 2020 guidance
Fierce Pharma
Fri, 10/27/17 - 11:10 am
Otezla
Celgene
How Big of a Deal Is Celgene's Flop?
Motley Fool
Sat, 10/21/17 - 10:23 am
Celgene
GED-301
Crohn’s disease
ozanimod
Otezla
5 Reasons Celgene Will Be a Top Biotech Stock for the Next Decade
Motley Fool
Thu, 03/9/17 - 09:54 am
Celgene
Revlimid
Pomalyst
Abraxane
Otezla
Celgene's Fastest-Growing Drugs
Motley Fool
Thu, 01/26/17 - 07:00 pm
Celgene
Otezla
Pomalyst
What's Next For Celgene
Motley Fool
Wed, 01/11/17 - 10:13 am
Celgene
JPMHC 2017
Otezla
ozanimod
Revlimid
Pomalyst
The FDA issues untitled letters to Sanofi and Celgene over distracting ads
Medical Marketing and Media
Fri, 12/16/16 - 09:43 am
FDA
drug ads
Sanofi
Celgene
Toujeo
Otezla
Pages
« first
‹ previous
1
2
3
next ›
last »